Numbers

Thesis in one paragraph

Build King is a US$280M (HK$2.2bn) market-cap Hong Kong civil-engineering contractor that does US$1.85bn of revenue at a stubborn 3-4% net margin, yet sits on US$197M of cash against just US$10M of bank debt — so roughly 70% of the equity value is net cash, and the operating business is implicitly capitalised at less than US$95M, or about 1x EBITDA. The market is finally noticing: the stock is up about 62% over the last 12 months on strong H1 FY2025 earnings (PAT +21% YoY, EPS US$0.018) and a US$3.8bn-plus public-works orderbook, but the trailing P/E is still around 5x and the dividend yield around 6%. The single metric that will rerate or derate this stock is net-margin durability — at the current valuation any sustained move toward 4-5% PAT margin (vs about 3% in FY2024) compounds straight into the multiple.

Currency note. Figures shown in US$ are converted from HKD at period-end FX (frankfurter.app rates in data/fx_rates.json). HKD has been on a tight USD peg (~7.78-7.85) for decades, so HKD/USD figures move almost in lockstep.

label

$0.225 (HK$1.77)

label

$280M (HK$2,198M)

label

$186M (HK$1,455M)

label

$1.85bn (HK$14.4bn)

label

5.1x

label

6.2%

1. What is this company economically?

A Tier-1 Hong Kong civil and building contractor: roads, MTR rail, foundations, marine works, tunnels, structural steel. Revenue scales with the public-works tendering cycle; margins are thin (gross around 8%, net around 3%) and capital intensity is low (FY2024 capex US$13M on US$1.85bn revenue equals 0.7%). Working capital — specifically contract-asset balances of US$518M vs US$741M in current liabilities — is the real balance-sheet line that moves earnings.

Loading...
Loading...

Revenue compounded at 17% CAGR over FY20-FY24 (US$984M to US$1,850M) but the FY2020 net margin (5.8%) was a high-water mark inflated by mix; FY2024 finished at a sub-3% net margin as fair-value losses on FVTPL investments, JV writedowns and admin-cost pressure compressed the bottom line even as the topline broke through US$1.85bn for the first time.

Recent direction — H1 FY2025 inflection

Loading...

H1 FY2025 revenue +6.6%, PBT +22%, PAT attributable to owners +20.5%, EPS +21%. That is the numerical event behind the +62% one-year share-price move — not a topline boom, but a clear margin recovery off the FY2024 trough.


2. Is it healthy and durable?

Quality scorecard

GuruFocus rankings (Quality Score, Predictability, Altman Z, Piotroski F, Beneish M) were not retrievable for HKEX micro-caps in this run. What we can score from the audited statements:

No Results

In two sentences: balance sheet is the headline strength — US$197M of cash against US$10M of bank loans is unusually clean for a HK contractor — but margin volatility is the headline risk, because 3-6% operating margins mean a single mispriced project or FVTPL loss (FY2023 saw US$16M of those) can swing the P&L by a quarter.

Cash generation — are the earnings real?

Loading...
Loading...

3-year average FCF/NI is roughly 1.6x — earnings are not just real, they understate cash generation because contract-asset releases periodically dump cash into the operating line (FY2022 was a notable example at US$144M vs US$55M of reported NI). The flip side is FY2023, where contract-asset build-up dragged CGO to US$56M; that volatility is structural to project-finance accounting.

Capital allocation

Loading...

Capital allocation is dividend-first, then deleverage, then small capex — no buybacks (parent Wai Kee Holdings owns the controlling stake), no M&A. FY2024 net loan repayment of US$17M took bank borrowings down 65% YoY. The US$197M cash pile sits idle — it is the single largest source of investor frustration and the single largest source of upside if management reverses course on capital return.

Balance sheet health

Loading...

The bars below zero on the dark side tell the whole leverage story: this company has been net cash since at least FY2022, and the cash position is widening even as equity grows. There is no Altman-Z stress to discuss; the question is the opposite — capital efficiency.


3. What does the market think?

Loading...

Five years of dead-money chop (US$0.11-0.15) ended in mid-2025 when H1 results landed. The +62% one-year move re-rates the stock from roughly 3.0x trailing P/E to about 5.1x — but that is still below the typical HK construction multiple of 6-8x.

Valuation today vs the franchise's own history

Loading...

5-year average trailing P/E around 3.9x; current 5.1x. Even after the rally the stock is barely back to its own mid-cycle multiple — and on an EV basis the rerating has barely begun, because the cash pile keeps growing in lockstep with the price.

metric

5.1x

metric

~1.0x

metric

0.83x

metric

70%

metric

6.2%

metric

32%

Peer comparison

No Results

Peer financials beyond price/market-cap snapshots were not in the data feed (no income statements were fetched for the peer set); the table pairs Yahoo-sourced market data with structural notes from the company-research file. Wai Kee Holdings consolidates Build King so its standalone metrics are intentionally not aggregated. The peer gap that matters: BUILDKINGH and CSCI both trade near 5x P/E, but BUILDKINGH carries net cash equal to 66% of its market cap while CSCI runs leveraged. Same multiple, very different risk-adjusted earnings yield.


4. Fair value & scenarios

Three triangulating methods, all in US$ per share:

No Results

Base case anchors on 7x trailing-cycle EPS of about US$0.041 (between FY24 US$0.045 and the 5y average US$0.038) — that is still below the HK construction-peer median multiple. Bear case strips the operating business to a balance-sheet liquidation value; bull case requires both margin recovery to 3.5%-plus and a partial cash distribution.


Close — confirm, contradict, watch

The numbers confirm that Build King is a structurally cash-generative HK contractor with a fortress balance sheet (net cash 55% of book equity) and double-digit ROE through cycles. They contradict the popular framing that this stock has already rerated — at 5.1x P/E and EV/EBITDA near 1x, the rerating has barely started, and roughly 70% of the equity value is already collateralised by cash. What to watch over the next 12 months: whether H2 FY2025 sustains the 4%-plus pretax-margin trajectory of the half-year results, and whether the FY2025 final dividend (declared March 2026) signals a payout-ratio step-up that monetises the idle cash pile — that single line will tell you whether the multiple goes from 5x to 8x or stays trapped at deep-value forever.